CHICAGO ― The long-term side effects of hypofractionated postoperative prostate bed radiotherapy (HYPORT) for prostate cancer are similar to those of conventional radiotherapy, a new study concludes. “Hypofractionation is a strategy for shortening treatment by giving larger doses per fraction…

For over a decade, the influential National Comprehensive Cancer Network (NCCN) has been recommending that men with low-risk prostate cancer be offered active surveillance as the lone “preferred” initial treatment option. But the NCCN has now reversed this long-standing recommendation…

Metastatic castration resistant prostate cancer (mCRPC) can be classified as either luminal or basal and, as in primary tumors, the distinction has important prognostic and therapeutic implications, concludes a new report in JAMA Oncology. Furthermore, the classification is “an important…

During the initial COVID-19 lockdown, the odds of Black men undergoing surgery for untreated nonmetastatic prostate cancer dropped by 94%, but for White men, there was no change, new data show. Before the pandemic, “there was no difference between White…

Loneliness among middle-aged men ups their risk of cancer, and being single at the time of diagnosis confers a worse prognosis, suggest results from a longitudinal Finnish study with a mean follow-up of 20 years. The study also found that…